Whether leukocytes exert an influence on vascular function in vivo is not known.
Introduction
Circulating neutrophils interact with the vessel wall through the action of adhesion molecules including P-and L-selectins. Although the mechanisms by which they bind to endothelium, roll, adhere and extravasate are understood, whether neutrophils themselves exert functional influences on the vessel wall itself has not been studied in vivo. There are several potential mechanisms by which these cells may regulate vascular function in vivo.
On activation of NADPH oxidase (respiratory burst), they generate superoxide (O 2
•-), a reactive oxygen species that reacts with nitric oxide (NO), the primary mediator of endothelium-dependent relaxation in large vessels 1, 2 . NADPH oxidase-mediated NO consumption occurs immediately on activation of neutrophils by fMLP, and rates of NO removal are 2-3-fold greater than corresponding O 2
•--generation rates 3 . This could have significant consequences for the ability of NO to maintain vascular tone in vivo, especially during inflammation. Reaction of NO with O 2 •-forms peroxynitrite (ONOO -), a powerful oxidant and nitrating agent that may itself lead to vascular dysfunction through protein and lipid modification, and thiol depletion 1 . ONOO -nitrates prostacyclin synthase, the enzymatic source of another important endothelial-derived vasorelaxant, prostacyclin (PGI2) 4, 5 .
Neutrophils also may remove NO indirectly through myeloperoxidase (MPO)-catalysed reactions. Following degranulation, MPO binds to the endothelium where it can potentially remove NO during peroxidase turnover 6, 7 . Apart from direct oxidative reactions, neutrophils could influence vascular function through release of mediators that exert direct vasoactive effects, including cytokines, adenosine, proteases and phospholipases. Finally, through
interactions with adhesion molecules they may activate endothelial signal transduction, although this is less well understood.
Previous experiments have addressed the idea that neutrophils may modulate vascular function by examining vascular tone in isolated aortic rings in vitro. Addition of activated neutrophils prevented or reversed endothelium dependent-relaxation or elicited a O 2
•--dependent vasoconstriction of rabbit or cat arteries, consistent with a role for oxidative inactivation of NO by the cells 8, 9 . Separately, other studies implicated prostaglandins or leukotrienes in the vasoconstrictive effect of neutrophils 10, 11 . However, studies have not addressed the ability of neutrophils to modulate vascular function in vivo. To address, we utilised a well characterized murine model of neutropenia involving intraperitoneal injection of anti-GR-1 12, 13 . Genetic and pharmacologic approaches were employed to determine the influence of neutrophils on blood pressure and in vitro vascular function in otherwise healthy mice.
Materials and Methods.
Animal studies All animal experiments were performed in accordance with the United Kingdom Home Office Animals (Scientific Procedures) Act, 1986. 8-10 week old, male wildtype BALB/c mice, IFN-γ -/-BALB/c mice, C3 -/-C57Bl/6, iNOS -/-C57Bl/6 mice and C57Bl/6 mice (Charles River, UK), were kept in constant temperature cages (20-22°C) and given free access to water and standard chow [14] [15] [16] . Celecoxib was given in chow (400 mg/kg/day), Enrofloxacin (Baytril, Dunlop's Veterinary Supplies, Dumfries, UK), was given in drinking water (0.4g/L). All experiments, except for iNOS -/-, C3 -/-and their controls were performed using Balb/C mice. Controls for these two strains were age and gendermatched C57BL/6 mice.
Neutrophil depletion Neutrophils were depleted using the antibody RB6-8C5, a rat antimouse IgG2b directed against Ly-6G, previously known as Gr-1, an antigen on the surface of mouse neutrophils 17 . The antibody was prepared for injection by dilution with sterile PBS under aseptic conditions. Doses were 150 µg on day 0; 300 µg on days 2, 4 and 6.
Alternatively, mice received an equal dose of a control antibody, GL113.
Blood pressure measurement Systolic blood pressure (BP) was measured daily at the same time of day, for 3 -5 days before neutrophil depletion (training) and for 8 days after depletion, by 'tail-cuff plethysmography' (Duo 18, World Precision Instruments, Florida). All BP measurements were carried out at 24 -26°C. µM acetylcholine (ACh) was added to assess endothelial integrity. Any rings that did not maintain contraction to PE, or relaxed <50% of the PE-induced tone after addition of ACh (1 µM) were discarded. No differences in the number of rings discarded between wild-type and neutrophil-depleted vessels were observed. Rings were washed for 30 min, after which a cumulative concentration-response curve to PE was constructed (1 nM to 0.1 mM)
Isometric tension functional studies
to assess vasoconstrictor activity. The tissues were then washed for 60 min to restore basal tone before contracting to ~80% of the 0.1 mM PE-induced response. Once a stable response to PE was observed, cumulative concentration response curves were constructed to ACh (1 nM to 10 µM), and then after a 30 min wash, to DEA-NONOate (Cayman, 0.1 nM to 0.1 mM), to assess endothelium-dependent and -independent relaxations, respectively.
Experiments were repeated in the presence of either 300 µM L-nitroarginine-methyl ester (L-NAME), or 10 µM 1400W with constriction and dilation curves being constructed as described previously. Responses were expressed as a percentage of either baseline tension (vasoconstriction) or contracted tension (vasodilation). Responses from patent rings of each animals (3-4 rings) were combined to produce an average for each same (n).
Western blot analysis.
Western blotting was performed as described previously 18, 19 .
Leukocytes were prepared from control blood by hypotonic lysis of whole blood. Cells were Immunohistochemistry The decending thoracic aorta was removed, cleaned of adipose tissue, and fixed in paraffin wax. 10 µm sections were taken using a microtome and methanol-fixed on glass slides, permeablised using 0.1% (w/v) Triton X-100/PBS, and blocked using 1% (w/v) bovine serum albumin (BSA)/PBS. MPO or iNOS expression was visualised using either rabbit anti-MPO Stable isotope-dilution gas chromatography-mass spectrometry Urine was collected in metabolic cages over a 24 hour period from control and neutropenic (day 2 to day 3) Balb/c mice. 4 mice were kept in each cage and the urine from these pooled to generate a single sample (n = 3 separate cages). GC/MS was used to detect and quantify the presence of the prostacyclin metabolite 2,3-dinor-6-keto prostaglandin F 1α (2,3-dinor-6-keto PGF 1α ) 20 .
Inhibition of complement in vivo BPs were measured in wild-type Balb/c mice administered RB6-8C5 with or without co-administration of the anti-complement C5
antibody BB5.1 (1 mg i.p, day 0 and day 2). BB5.1 was also administered alone as a control.
Comparing complement-activating capacity of mAb RB6-8C5 with the control, GL113
RB6-8C5 is a rat IgG2b antibody, an isotype previously reported to be complementactivating 21 . Absorbance values were read at 490nm in a Dynex ELISA plate reader. 
LPS assay

Results
RB6
-8C5 specifically depletes neutrophils in mice 1 day after injection with RB6-8C5, neutrophil counts had decreased significantly (e.g. 0.04 ± 0.03 x 10 6 cells.ml -1 vs 1.1 ± 0.1, day 1 versus day 0, mean ± SEM, p < 0.001, n = 3,) and remained depleted for up to 8 days (Fig 1 A) . The monocyte or lymphocyte counts did not change significantly. These data confirm that RB6-8C5 specifically depletes neutrophils without affecting monocyte or lymphocyte numbers as previously shown 23 . Administration of an equal dose of a control antibody, GL113, did not result in any significant change in circulating leukocytes ( Fig 1B) .
Neutrophil depletion causes progressive hypotension and aortic constriction defect in mice. Administration of RB6-8C5 was associated with a significant fall in systolic blood pressure (BP), over 3 days (104.0 ± 2.8 mmHg vs 88.0 ± 3.5 mmHg, on day 0 and day 3, respectively, mean ± SEM, p < 0.001, n ≥ 15) (Fig 1 C) . In contrast, i.p. administration of a control antibody (GL113), had no effect on BP (99.3 ± 2.8 mmHg, vs 104.0 ± 2.8 mmHg on day 3 and day 0, respectively, mean ± SEM, p = 0.2599, n ≥ 10) (Fig 1 C) . Between days 4-7, significant rises in BP were seen with both RB6-8C5 and GL113, suggesting that administration of antibody per se may cause side-effects, e.g by immune complex
formation (data not shown). In vitro, aortae from neutropenic mice (day 3) exhibited a significant attenuation in phenylephrine (PE)-induced vasoconstriction compared to controls (Fig 1 D) . These data show defects in vasoconstriction both in vivo and in vitro.
Elevated iNOS is responsible for the decreased BP and vasoconstriction in neutropenic mice.
To explore the mechanisms involved, regulation of tone by aortae from control and neutropenic mice (day 3) were compared in the presence of signaling inhibitors.
Pre-incubation of aortic rings from healthy mice with the non-specific NOS inhibitor L-NAME (300 µM, 15 min) slightly but not significantly enhanced vasoconstriction to PE (Fig   1 E) . In contrast, aortae from neutrophil-depleted animals exhibited a significantly enhanced vasoconstriction to PE in the presence of L-NAME (Fig 1 E) . Indeed, L-NAME normalized vasoconstriction of rings from neutropenic aminals to levels comparable with healthy controls. Endothelial-dependent relaxation to ACh was unaffected by neutropenia indicating that eNOS bioactivity is unchanged (Fig 1 F) . However, a role for iNOS is indicated since the specific inhibitor 1400W (10 µM, 30 min) normalized PE constriction, similar to L-NAME (Fig 1 G) . Furthermore, in vivo deletion of iNOS totally prevented the neutropenia-dependent fall in systolic BP (Fig 2 A) . Finally, using immunohistochemistry, an increase in iNOS staining was seen to co-localize with smooth muscle fibres in neutropenic vessels (Fig 2 B,C) .
Neutropenia-dependent hypotension requires IFN-γ signaling. Neutrophil depletion in
IFNγ -/-mice did not cause hypotension (Fig 2 D) . Furthermore, aortic rings from neutropenic IFNγ -/-mice constricted normally to PE in vitro (Fig 2 E) .
Neutrophil depletion requires complement C3 but not C5, and does not result in intravascular degranulation of neutrophils. To further understand the mechanisms involved, the role of complement and intravascular neutrophil activation was tested as follows.
In vivo inhibition of complement C5 during neutrophil depletion. Systolic BP was
determined in mice administered anti-C5 Ab (BB5.1, 1 mg i.p.), which blocks the common terminal pathways, during induction of neutropenia. BB5.1 alone (1 mg i.p.) had no effect on systolic BP, nor did it prevent or enhance the hypotensive effect of RB6-8C5, or inhibit clearance of neutrophils (Fig 3 A,B) .
Direct activation of complement by antibodies.
The ability of both RB6-8C5 and the control antibody, GL113 to activate complement in vitro was compared by measuring C3 fragment deposition from mouse serum by immobilised mAbs. Complement was identically activated in a dose-dependent manner by either mAb (Fig 3 C) .
Examination of neutrophil depletion and blood pressure in C3
-/-mice. Systolic blood pressure and neutrophil counts following RB6-8C5 administration was unchanged from control C3 -/-mice, who have normal basal blood pressure (Fig 3D) 24 . This implicates C3b opsonization of neutrophils in their RB6-8C5-mediated clearance.
Examination of neutrophil activation and degranulation in the vasculature in vivo.
We examined for the presence of myeloperoxidase (MPO) which comprises approximately 5% of neutrophil protein, both in plasma and on the endothelium of aortic rings, where it is known to localize following neutrophil degranulation in vivo 6 .
Western blotting of plasma from neutropenic mice (day 1 post-RB6-8C5) did not demonstrate MPO, and using immunohistochemistry, MPO was not observed on aortic endothelium (Fig 4 A,B) .
Involvement of bacteria in mediating the hypotensive response to neutropenia.
To examine the potential role of bacterial products, Enrofloxacin (a fluoroquinoline antibiotic) was administered 3 days before, and during induction of neutropenia. While this broad-spectrum antibiotic had no effect on basal blood pressure, there was a partial and significant inhibition of the neutropenia-induced fall in blood pressure (Fig 4C) .
Quantitation of endotoxin in plasma from healthy and neutropenic (day 3) mice revealed no differences (Fig 4 D) . This suggests other bacterial products are likely to be involved, for example peptidoglycans, lipotechoic acids, etc.
Mice exhibit an increase in 2,3-dinor-6-keto PGF 1α in urine during neutropenia. The potential role of COX-2-derived prostacyclin in mediating the fall in blood pressure was examined by administering celecoxib during induction of neutropenia. The dose used has been shown to inhibit systemic prostacyclin generation by over 70% 25 . There was no effect of celecoxib administration on blood pressure either before or during neutropenia induction (Fig 4C) . Furthermore, examination of PE vasoconstriction by aortae in the presence of indomethacin or celecoxib failed to implicate COX-2 in the decreased PE vasoconstriction observed (not shown). However, neutropenia was associated with a significant elevation in systemic generation of prostacyclin as determined by measuring urinary excretion of its stable metabolite 2,3-dinor-6-keto prostaglandin F 1α (2,3-dinor-6-keto PGF 1α ) in mouse urine at days 0 and 3 (Fig 4 E) .
Discussion
Neutrophils are orchestrating cells of the innate immune system, circulating through the body and extravasating to sites of infection and injury where they perform important roles in host defence. While the mechanisms by which they migrate and activate are well characterised, whether their interaction(s) with the vasculature during normal circulation has functional consequences on blood vessel behaviour has not been studied before.
Herein, we uncovered a novel facet of neutrophil biology, namely the requirement of these cells for maintenance of normal vascular tone in otherwise healthy mice. 28 .
In our studies, neutropenia was induced by immunodepletion of Gr-1 +ve cells 17, 23 .
The protocol resulted in a complete and selective removal of neutrophils within 24 hrs that persisted for up to 7 days (Fig 1 A,B) . This model has been extensively used by others to study immune responses and behaves similarly to chemical neutropenia, e.g. induced by vinblastine, cyclophosphamide or Gfi1-deficiency [29] [30] [31] . The mechanism involves opsonization of antibody-coated cells with C3b, then their removal through the reticuloendothelial system, since C3 -/-mice but not C5 -/-mice were protected against RB6-8C5-induced neutropenia (Fig 3) . There was no evidence of intravascular activation of neutrophils, since MPO was not found either in plasma or localized to vascular endothelium (Fig. 4) .
Hypotension occurred within three days of neutropenia, coinciding with an inability of the aorta to maintain tone in vitro (Fig 1 C,D) . fMLP-activated human neutrophils consume NO in vitro exclusively through NADPH oxidase, therefore inhibition of NO consumption through neutrophil depletion was considered 3 . However, neutropenia was complete by day 1, while onset of hypotension was more gradual. This instead suggested a mechanism involving alterations in gene expression. Pharmacological and genetic studies established that elevated NO generation was responsible and that this was generated exclusively via iNOS (Fig 1 E-G, 2 A-C) . iNOS induction involved IFNγ, although elevations in mRNA for this cytokine were not found in aortic tissue of neutropenic mice (Fig 2, D ,E, and data not shown). This suggests that IFNγ signalling is not upregulated via changes in its protein level. Alternatively, it may involve regulation of SOCS1 or PIAS1, proteins which inhibit by preventing IFNγ-mediated STAT1, signaling.
The effect of antibiotic indicated that bacterial products were involved, but not LPS since its plasma levels were unchanged (Fig 4 C,D In a wound healing model, neutrophils exert an active anti-inflammatory action in vivo via inhibiting tissue TNFα and IL1β synthesis, through generation of an unknown factor of less than 3 KDa, but this factor has not been identified 23 . In the light of our data, a role for bacteria stimulating inflammation in that study cannot be excluded. We looked for changes in lipid signalling mediators (< 3 KDa) that decrease blood pressure or inflammation. Neutropenic mice generated more prostacyclin in vivo (Fig 4 E) , however vascular tone was not restored using prostaglandin H synthase inhibitors in vitro or in vivo (Fig 4 C and data not shown) . Lipoxin A4 (LXA4), an anti-inflammatory lipid generated by neutrophils was not detected in plasma of either control or neutropenic mice. Previous studies have reported levels of LXA4 of 5 ng/ml in murine plasma 36 . This would be easily detected by our mass spectrometry method, which has a limit of quantitation for eicosanoids around 1 pg. The discrepancy may be due to use of ELISAs to measure LXA4, a technique known to be susceptible to overestimation, as recently described 37 . We also measured TGFβ1, since inflammatory-challenged neutropenic mice generate less, and mice lacking this cytokine have elevated iNOS and IFNγ signaling in vivo 23, 38 . However, we did not detect changes in plasma TGFβ1 or aortic TGFβ1 mRNA in our model (not shown).
While our study showed that the most likely effect of IFNγ was to alter iNOS expression and NO generation, it should be appreciated that this cytokine may exert additional influences that could contribute to altered vasoconstriction. These may include changes in IFNγ-regulated vessel wall expression of recently described NOX isoforms, altered mitochondrial oxidative metabolism and alterations in NOS coupling [39] [40] [41] These studies indicate that neutrophils actively exert an anti-inflammatory effect in constriction dose-response curves were constructed in thoracic aortae from control mice and mice depleted of neutrophils for 3 days using myography as described in Materials and Methods (n ≥ 4, mean ± SEM). ***, p < 0.001 vs control using two way ANOVA. Panel E. L-NAME restores constriction to control levels in aortae from neutropenic mice. Doseresponses curves to PE were determined in thoracic aortae from control mice and mice depleted of neutrophils for 3 days in the presence or absence of 300 uM L-NAME (n ≥ 4, mean ± SEM). ***, p < 0.001, neutropenic + L-NAME vs neutropenic using two way ANOVA. Panel F. Acetylcholine-relaxation is normal in aortae from neutropenic mice.
Relaxation dose-response curves to ACh in PE-preconstricted aortae from control and neutropenic mice (day 3) were constructed (n ≥ 4, mean ± SEM). Panel G 1400W restores constriction to control levels in aortae from neutropenic mice. PE-induced constriction responses in aortae from control and neutropenic mice (day 3) in the presence or absence of 10 uM 1400W were constructed (n ≥ 4, mean ± SEM). ***, p < 0.001, neutropenic + 1400W vs neutropenic using two way ANOVA. Aortic ring functional responses were determined as described in Materials and Methods. The prostacyclin metabolite 2,3-dinor-6-keto prostaglandin F 1α was quantified in mouse urine collected over a 24 hours period from control and neutropenic (days 2 -3) using a sensitive and specific GC/MS technique (n ≥ 3, mean ± SEM). *, p < 0.05 vs control using one-tailed Student's t-test. 
